Basal and 24-h C-peptide and insulin secretion rate in normal man
- PMID: 3552817
- DOI: 10.1007/BF01788901
Basal and 24-h C-peptide and insulin secretion rate in normal man
Abstract
An understanding of the metabolic abnormalities rising from inappropriate insulin delivery in diabetic patients demands a knowledge of 24-h and basal insulin secretion rates in normal man. We have used biosynthetic human C-peptide to determine its kinetic parameters in 10 normal subjects and applied these to measurements of plasma concentrations in the same subjects to determine pancreatic secretion rate. Metabolic clearance rate measured by stepped primed infusion of biosynthetic human C-peptide at rates of 10, 19 and 26 nmol/h was 4.7 +/- 0.7 (+/- SD) ml X kg-1 X min-1, and was independent of infusion rate. Fractional clearance (T1/2, 26 +/- 3 min) and distribution volume (0.178 +/- 0.039 l/kg) were calculated from the decline in concentration after cessation of the highest rate infusion. Basal insulin secretion calculated from the C-peptide metabolic clearance rate and plasma concentrations for the period 02.00 to 07.00 hours was 1.3 +/- 0.4 U/h. Over 24 h total insulin secretion on a standard high carbohydrate diet was 63 +/- 15 U, calculated from the area under the C-peptide concentration curve. Basal insulin secretion, therefore, accounted for 50 +/- 8% of total insulin secretion. Although only 5.6 +/- 1.1% of C-peptide was detected in 24-h urine collections, urinary C-peptide excretion was significantly related to 24-h C-peptide secretion (r = 0.74, p less than 0.02).
Similar articles
-
Twenty-four hour C-peptide and insulin secretion rates and diurnal profiles of glucose, lipids and intermediary metabolites in cirrhosis.Clin Sci (Lond). 1992 Nov;83(5):597-605. doi: 10.1042/cs0830597. Clin Sci (Lond). 1992. PMID: 1335398
-
Estimation of insulin secretion rates from C-peptide levels. Comparison of individual and standard kinetic parameters for C-peptide clearance.Diabetes. 1992 Mar;41(3):368-77. doi: 10.2337/diab.41.3.368. Diabetes. 1992. PMID: 1551497
-
Use of biosynthetic human C-peptide in the measurement of insulin secretion rates in normal volunteers and type I diabetic patients.J Clin Invest. 1986 Jan;77(1):98-105. doi: 10.1172/JCI112308. J Clin Invest. 1986. PMID: 3511094 Free PMC article.
-
C-peptide as a measure of the secretion and hepatic extraction of insulin. Pitfalls and limitations.Diabetes. 1984 May;33(5):486-94. doi: 10.2337/diab.33.5.486. Diabetes. 1984. PMID: 6373457 Review.
-
Current approaches to measurement of insulin secretion.Diabetes Metab Rev. 1986;2(3-4):315-29. doi: 10.1002/dmr.5610020306. Diabetes Metab Rev. 1986. PMID: 3527618 Review.
Cited by
-
Understanding the Clinical Profile of Insulin Degludec, the Latest Basal Insulin Approved for Use in Canada: a Narrative Review.Diabetes Ther. 2020 Nov;11(11):2539-2553. doi: 10.1007/s13300-020-00915-w. Epub 2020 Sep 17. Diabetes Ther. 2020. PMID: 32940879 Free PMC article. Review.
-
[Diagnosis and insulin therapy of type 1 diabetes mellitus (Update 2019)].Wien Klin Wochenschr. 2019 May;131(Suppl 1):77-84. doi: 10.1007/s00508-019-1493-6. Wien Klin Wochenschr. 2019. PMID: 30980145 Review. German.
-
Plasma C-Peptide and Risk of Developing Type 2 Diabetes in the General Population.J Clin Med. 2020 Sep 17;9(9):3001. doi: 10.3390/jcm9093001. J Clin Med. 2020. PMID: 32957570 Free PMC article.
-
Quantitative and qualitative differences in basal and glucose- and arginine-stimulated insulin secretion in healthy subjects and different stages of NIDDM.Acta Diabetol Lat. 1990 Jul-Sep;27(3):197-213. doi: 10.1007/BF02581332. Acta Diabetol Lat. 1990. PMID: 2075783
-
Chronic Intranasal Insulin Does Not Affect Hepatic Lipids but Lowers Circulating BCAAs in Healthy Male Subjects.J Clin Endocrinol Metab. 2017 Apr 1;102(4):1325-1332. doi: 10.1210/jc.2016-3623. J Clin Endocrinol Metab. 2017. PMID: 28323986 Free PMC article. Clinical Trial.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Miscellaneous